Delayed preconditioning of the human myocardium: signal transduction and clinical implications.
D000109:Acetylcholine / Q000494:pharmacology; D000368:Aged; D000470:Alkaloids; D000841:Anisomycin / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D053119:Benzophenanthridines; D046508:Culture Techniques; D003652:Decanoic Acids / Q000494:pharmacology; D003981:Diazoxide / Q000494:pharmacology; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006325:Heart Atria; D006801:Humans; D006880:Hydroxy Acids / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D019157:Ischemic Preconditioning, Myocardial; D008297:Male; D008875:Middle Aged; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D017202:Myocardial Ischemia / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D010617:Phenanthridines / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D026902:Potassium Channel Blockers / Q000494:pharmacology; D015221:Potassium Channels / Q000378:metabolism; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology; D015398:Signal Transduction; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013997:Time Factors; D048051:p38 Mitogen-Activated Protein Kinases
D000470:Alkaloids; D000959:Antihypertensive Agents; D053119:Benzophenanthridines; D003652:Decanoic Acids; D004791:Enzyme Inhibitors; D006880:Hydroxy Acids; D007093:Imidazoles; D010617:Phenanthridines; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D011725:Pyridines; D010656:Phenylephrine; C052853:5-hydroxydecanoic acid; D000841:Anisomycin; C016299:chelerythrine; D011493:Protein Kinase C; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; D000109:Acetylcholine; D013755:Tetradecanoylphorbol Acetate; D003981:Diazoxide; C093642:SB 203580